Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.66 | 4.66 | 0.00 |
Stocks | 94.20 | 94.20 | 0.00 |
Other | 1.14 | 1.14 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.60 | 13.40 |
Price to Book | 1.35 | 2.01 |
Price to Sales | 0.94 | 1.34 |
Price to Cash Flow | 7.71 | 8.70 |
Dividend Yield | 3.82 | 3.09 |
5 Years Earnings Growth | 8.22 | 10.14 |
Name | Net % | Category Average |
---|---|---|
Industrials | 27.15 | 11.99 |
Financial Services | 19.37 | 18.88 |
Healthcare | 14.78 | 14.63 |
Consumer Defensive | 10.93 | 10.57 |
Basic Materials | 10.59 | 5.27 |
Consumer Cyclical | 6.12 | 9.05 |
Energy | 3.77 | 6.27 |
Technology | 3.77 | 12.23 |
Communication Services | 2.66 | 8.08 |
Real Estate | 0.85 | 4.13 |
Number of long holdings: 65
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 4.17 | 76.00 | +0.21% | |
Kemira Oyj | FI0009004824 | 3.48 | 18.63 | -0.32% | |
BAE Systems | GB0002634946 | 3.47 | 1,287.00 | -0.85% | |
Diageo | GB0002374006 | 3.46 | 2,337.0 | -1.16% | |
Roche Holding Participation | CH0012032048 | 3.07 | 252.60 | +0.48% | |
J&J | US4781601046 | 3.02 | 154.52 | -0.01% | |
Safran | FR0000073272 | 2.97 | 218.10 | -0.05% | |
Fresenius SE | DE0005785604 | 2.80 | 32.965 | +0.05% | |
Novartis | CH0012005267 | 2.70 | 92.27 | +0.37% | |
FMC | US3024913036 | 2.64 | 59.97 | -1.07% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Tweedy, Browne Global Value | 5.2B | 4.53 | 3.07 | 4.85 | ||
Tweedy, Browne Value | 418.31M | 4.27 | 4.56 | 5.37 | ||
Tweedy, Browne Global Value II Ccy | 245.4M | 2.41 | 2.22 | 3.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review